MCP Antivirals/Antifungals Flashcards

1
Q

Oseltamivir

A

Tamiflu®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Docosanol

A

Abreva®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acyclovir

A

Zovirax®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Valacyclovir

A

Valtrex®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Famciclovir

A

Famvir®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Miconazole

A

Monistat®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Terconazole

A

Terazol®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tioconazole

A

Vagistat®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ketoconazole

A

Nizoral®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clotrimazole

A

Lotrimin®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fluconazole

A

Diflucan®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Itraconazole

A

Sporanox®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Voriconazole

A

VFEND®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Terbinafine

A

Lamisil®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nystatin

A

Nystop®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Griseofulvin

A

Grifulvin V® or Gris-PEG®

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Influenza: Morbidity/Mortality; Surface proteins targeted in treatment

A
  • Greater than 30,000 deaths/year
  • Hemagglutinin
    • allows virus to enter host cells
  • Neuraminidase
    • Allows release of new viral particles from host cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Signs and Symptoms of Influenza

A
  • Rapid onset of fever
  • Myalgia
  • Headache
  • Non-productive cough
  • Sore throat
  • Rhinitis
  • Symptoms resolve 3-7 days
    • Cough and malaise may persist for >2 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Influenza: Pathogenesis

A
  • Transmission via inhalation of respiratory droplets
  • Incubation period 1-4 days (2 day average)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Flu Prevention Strategies

A
  • Vaccination
    • Best way to prevent morbidity/mortality
  • Hand Hygiene
  • Respiratory etiquette
  • Contact avoidance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Tamiflu: MOA, take w/i…

A
  • Oseltamivir
  • Neuraminidase inhibitor to prevent release of virus from cell
  • Take w/i 48 hours of start of symptoms or else benefits go down
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Tamiflu Treatment Benefits

A
  • Viral replication decreased
  • Reduces duration of illness by 1 day
  • May reduce bronchitis, sinusitis, otitis media, antibiotic use, hospitalization, and pneumonia
  • Reducation in societal costs associated with flu
23
Q

Who should get Tamiflu

A
  • Very old: >75 yo
  • Very young: <2 yo
  • Hospitalized
  • High risk patients
  • Important to follow these guidelines, especially during shortages.
24
Q

Tamiflu SE

A
  • Nausea
  • Vomiting
  • Neuropsychiatric events
    • very rare
    • confusion, delirium, self-injury
    • younger kids of Japanese decent at higher risk
25
Dosing for Tamiflu: Treatment, prophylaxis, starting, dose adjustment
* Effective for Influenza A and B for patients age 1 and older * Treatment: 75 mg PO BID x 5days * Prophylaxis: 75 mg PO QD x10 days * must be used within 48 hours of symptom onset * Dose ajust for CrCL \<30mL/min and children \<40kg
26
Tamiflu Formulations/Administration
* Capsules * Suspension: 6mg/mL * Fridge (17 days) * Room Temp (10 days) * Shake well and may take with or without food
27
Current Flu Season
* Predominant Strain * H3N2 * Suseptible to Oseltamivir and Zanamivir (Relenza)-oral inhalation * Vaccination best way to prevent infection * H1N1 * H3N2 * B strain * CDC does not recommend quadravalent over trivalent, extra B not better * This year 90% A and 10% B strain. * 99% H3N2 and 1% H1N1 * 67% A strain has mutated *
28
Herpes Simplex Virus 1
* Herpes labialis (cold sores)
29
Herpes Simplex Virus 2
* Herpes genitalis (genital herpes) * acquired through sexual contact * Can transmit infection while asymptomatic
30
Herpes Zoster Virus
* Primary infection--\>Varicella--\>Chickenpox * Reactivation--\>herpes zoster--\>Shingles * Vaccines available
31
MOA Abreva
* Docosanol * Inhibits fusion of HSV envelope with cell membrane to stop spread of virus * Take at start of symptoms
32
MOA Acyclovir
* Intracellulary phosphorylated by viral thymidine kinase, then converted to triphosphorylated acyclovir by host cell kinase * Incorporated into viral DNA and causes strand termination and cell death
33
MOA Valacyclovir
* Prodrug of acyclovir * Better bioavailability (3-5x)
34
MOA Famciclovir
* Prodrug converted to penciclovir (Denavir®) * Denavir is an older topical cream
35
Herpes Antiviral Therapies
36
Herpes Genitalis: Dosing/Drug
* Acyclovir * Initial: * 200mg 5x/d for 7-10 days * 400mg TID for 7-10 days * Recurrent: * 200mg 5x/d for 5 days * 400mg TID for 5 days * Chronic * 400mg BID​ * ​Valacyclovir * Initial: * 1g BID for 10 days * Recurrent: * 500mg BID for 5 days * Chronic * 500-1000mg QD * ​Famyclovir * Initial: * 250mg TID for 7 days * Recurrent: * 200mg 5x/d for 5 days * 400mg TID for 5 days * Chronic: * 400mg BID
37
Herpes Labialis: Dosing/Drug
* Acyclovir * 400mg 5x/d for 5 days * Valacyclovir * 2g BID for 1 days * Famcyclovir * 1500mg x 1 dose
38
Herpes Zoster: Dosing/Drug
* Acyclovir * 800mg 5x/d for 7-10 days * Valacyclovir * 1g TID for 7 days * Famciclovir * 500mg TID for 7 days
39
Varicella: Dosing/Drugs
* Acyclovir * 800mg QID for 5 days ​
40
Herpes Antiviral Therapies Dosing
41
Herpes Antiviral Therapies: Counseling Pearls
* Docosanol (Abreva)-OTC cream indicated for herpes labialis * Use at first sign of reactivation * Apply 5 times a day (max 10 days) * Acyclovir, valacyclovir, famciclovir * Take with full glass of water/drink plenty of fluids * Prevents crystals from forming in kidneys * ​Initiate therapy within 24 hours of symptom onset (genitalis/varicella) * Initiate 48-72 hours after sign of rash (herpes zoster) * ​Higher doses for treatment of herpes zoster could cause N/V/D, constipation, headache * Chronic suppressive therapy for herpes genitalis * Recommended for individuals with 6 or more outbreaks per year * Decreases reoccurence by 70-80% * Stress safe sex practices * Disease can be transmitted in absence of symptoms * Reassure patients that minimal risk with long term therapy * Encourage adherance to daily suppressive therapy * Valacyclovir QD dosing vs. acyclovir BID times a day dosing. ​
42
Vulvovaginal Candidiasis: Overview
* Most common vaginal infection affecting women of childbearing age * Up to 75% of women-1 episode (50% more than 1 episode) * Normal vaginal flora (Candida) can become pathogen during a change in the vaginal environment * Antibiotic therapy * High levels of estrogen * Immune status * Vaginal pH * Pregnancy * Candida albincans is responsible for 80-90% of all infections
43
Vulvovaginal Candidiasis: Complicated/Uncomplication
* Uncomplicated: * Sporadic episodes * Mild symptoms * Majority of episodes are considered uncomplicated * Complicated * Reurrent (4 or more episode/yr) * Severe symptoms * Non-albican species * Immunocompromised * Pregnancy * Unconrolled diabetes
44
Vulvovaginal Candidiasis: Treatment
* ​Uncomplicated: * Topical antifungal x 1 dose, 3 days, or 7 days * All regiments equally effective * Price varies * Topical preferred over PO * Oral fluconazole: 150mg x 1dose * Complicated: * Severe Infection: * Topical antifungal x 7-14 days * PO Fluconazole 150mg x 3 doses * Pregnancy: * Topical antifungal x 7days * ​​Uncontrolled Diabetes: * Topical or PO x 7-14days * Recurrent: * Topical or PO x 7-14days * Maintenance fluconazole 150mg weekly times 6 months
45
Vulvovaginal Candidiasis Therapies
46
Oropharyngeal and esophageal candidiasis
* Infection can spread from oral mucosa into esophagus * Risk factors; inhaled corticosteroids, antibiotics, smoking, immunocompromised.
47
Dermatophytes
Ring-shaped, erythematous; well demarcated, scaly to vesicular region accomplished by puritis
48
Antifungal Medications: Organized by MOA
* Damage Fungal Cell Wall * Azole Antifungals * Ketoconazole * Clotrimazole * Fluconazole * Itraconazole * Voriconazole * Terbinafine * Nystatin * Inhibit mytosis * Griseofulvin
49
Antifungal Medication Formulations
Focus on which are OTC and what are topical
50
Antifungal Indication and Treatment Durations
Focus on Duration of Therapy
51
Counseling Pearls: Azole Antifungals
* Adverse reactions: N/V/D * Drug interactions: strong CYP3A4 and 2C9 inhibitor * oral contraceptives * Simvastatin * Warfarin * Take voriconazole 1-2 hours before meal * Ketoconazole and itraconazle need acid for absoroption (separate by antacide by 2 hours) * Monitor liver function
52
Counseling Pearls: Terbinafine
* Improvement in nailbeds may take months; cure rate approximately 40-75% of patients * Adverse reactions: * N/V/D, disorder of taste, indigestion, headache * Monitor liver function: report persistent nausea, fatigue, vomiting, dark urine, right upper abdominal pain, or jaundice
53
Counseling Pearls: Griseofulvin
* Drug of choice for tinea capitis * Adverse effects: * Rash, headache, photosensitivity, N/V/D, dizziness, drowsiness * Interactions: * Birth control pills: decreases effectiveness * Alcohol: flushing, tachycardia * Take with fatty meal to increase absorption